Sign Up to Receive Your Personalised Learning Resources
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Durvalumab + tremelimumab vs. doxorubicin in soft tissue sarcoma – MEDISARC study: Viktor Grünwald, ESMO 2023
View
Fruquintinib in Patients with Previously Treated Metastatic Colorectal Cancer
View
A Comprehensive Review of the Growing Landscape of Endocrine and Biologic Treatments for Hormone Receptor-positive Breast Cancer
View
Impact of T2D on efficacy of immune checkpoint inhibitors in patients with cancer: Alessio Cortellini
View
A New Frontier in the Treatment of Epidermal Growth Factor Receptor-mutated Non–Small-Cell Lung Cancer: Amivantamab-vmjw and Chemotherapy
View
sharing perspectives specific dees through the lens of a paediatric and an adult neurologist
View
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
View
Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
View
Expanding horizons in the treatment of endometrial cancer: How can data from ESGO 2023 guide clinical practice?
View
Dostarlimab for the Treatment of Endometrial Cancer: A Review
View